Consensus Novavax, Inc.

Equities

NVAX

US6700024010

Real-time Estimate Cboe BZX Other stock markets 02:33:22 2024-04-18 pm EDT			5-day change	1st Jan Change
3.93 ^USD	+1.03%		-8.49%	-18.02%

Apr. 15	Sector Update: Health Care Stocks Gain Monday Afternoon	MT
Apr. 15	Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla...

Evolution of the average Target Price on Novavax, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a7319f7b8ee19147f9cde3e0.N2vzPIbDCJETLH6rdoS7jcYbAM4cGARTiqFAhMJ7p9M.aCjBeNf2YOEqZ077Ibb-_PRhN7xLTzAV4MQxwpQJ4YZtAMZQvo8x-UdPPw~b00520670a5152783e326032fe3a18d2

Analyst Recommendations on Novavax, Inc.

Novavax Shareholder Shah Capital Pushes to Add 2 Nominees to Company's Board	Apr. 15	MT
Hedge fund Shah Capital urges Novavax board shake-up, FT says	Apr. 15	RE
Hedge fund Shah Capital urges board shake-up at Novavax over struggling Covid vaccine, FT reports	Apr. 15	RE
HC Wainwright Cuts Price Target on Novavax to $19 From $35, Keeps Buy Rating	Mar. 01	MT
B. Riley Trims Novavax's PT to $11 From $12 After Reaching Settlement on Gavi Arbitration Dispute, Keeps Buy Rating	Feb. 23	MT
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge	Jan. 12	RE
Job losses delight investors	Dec. 06
B. Riley Lowers Novavax's Price Target to $12 From $15 After Near-Term COVID-19 Sales Estimate Revisions, Maintains Buy Rating	Nov. 10	MT
Wall Street ends lower on healthcare losses, interest rate jitters	23-08-17	RE
B. Riley Upgrades Novavax to Buy From Neutral After Above-Consensus Q2 Beat, Says Turnaround Progressing; Retains $15 PT	23-08-09	MT
US govt tells vaccine makers to price updated COVID shots reasonably	23-07-13	RE
Will the Fed follow Australia's decision to hike rates?	23-06-06
B. Riley Raises Novavax's PT to $15 From $10, Says Q1 Financial Update 'Not As Bad As Feared'; Keeps Neutral Rating	23-05-10	MT
S&P, Nasdaq weak as manufacturing stokes Fed concerns	23-03-01	RE
B. Riley Downgrades Novavax to Neutral From Buy, Lowers Price Target to $10 From $29	23-03-01	MT
B. Riley Cuts Novavax's Price Target to $29 From $37, Maintains Buy Rating	23-02-17	MT
B. Riley Lowers Novavax's Price Target to $37 From $74, Keeps Buy Rating	23-01-09	MT
North American Morning Briefing : Rough Start For Futures, Focus Still on Rate Path	22-12-15	DJ
B. Riley Lowers Novavax's Price Target to $74 From $83, Keeps Buy Rating	22-11-10	MT
B. Riley Lowers Novavax's PT to $83 From $126 to Reflect Current Realities of COVID Booster Market Dynamics, Cuts Near-Term Estimates; Maintains Buy Rating	22-10-14	MT
JPMorgan Downgrades Novavax to Underweight from Neutral, Adjusts Price Target to $27 from $132	22-09-22	MT
B. Riley Securities Lowers Novavax's Price Target to $126 from $171 After Lower-than-Expected Q2 Results, Maintains Buy Rating	22-08-10	MT
Cowen Lowers Novavax's Price Target to $110 From $150, Maintains Outperform Rating	22-08-09	MT
B. Riley Lowers Novavax's PT to $171 from $181, Says Volatility to Shares Largely Attributed to Fast-Evolving Perception of Q2 Earnings Print; Keeps Buy Rating	22-07-25	MT
ANALYST RECOMMENDATIONS : Blackstone, Relx, Vodafone, Anglo American, Domino's Pizza...	22-07-25